perfluorobutane has been researched along with Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, Y; Moriyasu, F; Sugimoto, K; Yoshiyuki, K | 1 |
| Alaboudy, A; Chung, H; Hatanaka, K; Hyodo, T; Inoue, T; Kudo, M; Kumano, S; Moustafa, EF; Murakami, T | 1 |
2 other study(ies) available for perfluorobutane and Hepatitis C
| Article | Year |
|---|---|
Assessment of irreversible electroporation ablation zone using Kupffer-phase contrast-enhanced ultrasound images with Sonazoid.
Topics: Ablation Techniques; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Electroporation; Ferric Compounds; Gadolinium DTPA; Hepatitis C; Humans; Iron; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Oxides; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2014 |
Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomograph
Topics: Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Ferric Compounds; Gadolinium DTPA; Hepatitis B; Hepatitis C; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Oxides; Radiographic Image Enhancement; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2011 |